Vaccine Adjuvants and Autism: Analyzing DTAP, MMR

This research investigates the potential links between childhood vaccines, specifically DTAP, MMR, and other scheduled vaccines, and autism spectrum disorders. The investigation focuses on independent medical studies that utilize medical history data and experimental data to explore possible mechanisms of action. A primary area of interest is the gut-brain interaction hypothesis, examining how vaccine adjuvants might influence neurological development in children. Key relationships include analyzing the role of specific adjuvants present in vaccines and their potential impact on the gut microbiota and subsequent neural pathways. The research aims to understand these interactions and their relationship to autism outcomes. Studies of interest include those that provide a robust analysis of medical records, as well as experimental studies that highlight biological interactions at the cellular or systemic level. The context is limited to childhood vaccines, with a focus on understanding both physiological and epidemiological perspectives.